24,300 Shares in Astera Labs, Inc. $ALAB Acquired by Marex Group plc

by · The Markets Daily

Marex Group plc purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 24,300 shares of the company’s stock, valued at approximately $2,197,000.

Other large investors also recently bought and sold shares of the company. MRP Capital Investments LLC acquired a new position in shares of Astera Labs in the 2nd quarter valued at $318,000. Advisory Services Network LLC acquired a new position in Astera Labs in the second quarter valued at $692,000. Liontrust Investment Partners LLP grew its position in Astera Labs by 62.9% during the second quarter. Liontrust Investment Partners LLP now owns 52,349 shares of the company’s stock valued at $4,733,000 after acquiring an additional 20,220 shares during the period. Geneos Wealth Management Inc. increased its stake in Astera Labs by 121.2% during the second quarter. Geneos Wealth Management Inc. now owns 8,920 shares of the company’s stock worth $807,000 after acquiring an additional 4,887 shares during the last quarter. Finally, Caxton Associates LLP purchased a new position in shares of Astera Labs in the 2nd quarter worth about $14,807,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Trading Down 14.3%

Shares of ALAB stock opened at $148.85 on Friday. The firm has a fifty day simple moving average of $166.62 and a 200-day simple moving average of $153.61. The company has a market capitalization of $25.14 billion, a PE ratio of 134.10, a price-to-earnings-growth ratio of 2.77 and a beta of 1.51. Astera Labs, Inc. has a twelve month low of $47.13 and a twelve month high of $262.90.

Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.10. The firm had revenue of $230.58 million for the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The firm’s quarterly revenue was up 103.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Equities research analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Wall Street Analysts Forecast Growth

ALAB has been the subject of a number of research reports. Citigroup reiterated an “outperform” rating on shares of Astera Labs in a report on Tuesday. Cowen reiterated a “hold” rating on shares of Astera Labs in a research note on Wednesday, November 5th. Stifel Nicolaus raised their target price on shares of Astera Labs from $185.00 to $200.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Weiss Ratings restated a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, October 8th. Finally, Bank of America began coverage on Astera Labs in a report on Friday, October 3rd. They issued a “neutral” rating and a $230.00 price target for the company. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and eight have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $188.17.

Get Our Latest Report on ALAB

Insiders Place Their Bets

In related news, CFO Michael Truett Tate sold 11,430 shares of the business’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $1,653,806.70. Following the transaction, the chief financial officer owned 192,297 shares in the company, valued at approximately $27,823,452.93. The trade was a 5.61% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Jitendra Mohan sold 90,459 shares of the firm’s stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the sale, the chief executive officer owned 2,080,418 shares of the company’s stock, valued at approximately $301,015,680.42. This trade represents a 4.17% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 586,936 shares of company stock valued at $89,331,140. Insiders own 12.50% of the company’s stock.

About Astera Labs

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Read More

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).